Grant: Discovery Grants Program - Individual
Université de Montréal
$81,614.00
New technologies to understand the interplay of protein modifications in human diseases
FY 2015-16
Summary
This application is primarily centered on the development of novel mass spectrometry (MS) strategies and data mining approaches to profile the dynamic changes in protein modifications affecting important cellular processes such as transcriptional regulation, protein translocation and degradation that are often misregulated during cancer development. In mammalian cells, a large array of enzymes affects the biological activities of proteins through the covalent attachment of more than 200 different types of post-translational modifications (PTMs), many of them targeting the same amino acid (e.g. lysine residues can be modified by methylation, acetylation, ubiquitylation or sumoylation). Although MS has been a key technology in providing precise information on the nature and site of PTMs, these tasks remain challenging in view of the low abundance and the dynamic nature of these modifications. These difficulties are compounded with the lack of convenient affinity chromatography approaches to enrich modified proteins from complex cell extracts and determine the interdependence between different types of modifications. To address these challenges, we will develop specific enrichment and detection methods to identify and profile protein phosphorylation and sumoylation in human cells, and apply these technologies to determine paralog-specific SUMO substrates and how they are regulated in response to As2O3 and cytokines, which are known to affect protein sumoylation and subsequent proteasome degradation. The tools developed will be use to identify novel substrates, determine changes in site occupancy and correlate protein modifications with specific enzyme activities (e.g. modified sumoylated substrates targeted by specific E3 SUMO ligase or SUMO proteases). We anticipate that developments made as part of this proposal will not only expand the scope and application of large-scale proteomics and drug discovery programs but will also provide further insights on the regulation and significance of these modifications in human diseases.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
311598-2013
Name nom
Thibault, Pierre
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2013
Award amount
81614
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
3
Nb partie
5
Application title
New technologies to understand the interplay of protein modifications in human diseases
Keyword
NSERC
Application summary
This application is primarily centered on the development of novel mass spectrometry (MS) strategies and data mining approaches to profile the dynamic changes in protein modifications affecting important cellular processes such as transcriptional regulation, protein translocation and degradation that are often misregulated during cancer development. In mammalian cells, a large array of enzymes affects the biological activities of proteins through the covalent attachment of more than 200 different types of post-translational modifications (PTMs), many of them targeting the same amino acid (e.g. lysine residues can be modified by methylation, acetylation, ubiquitylation or sumoylation). Although MS has been a key technology in providing precise information on the nature and site of PTMs, these tasks remain challenging in view of the low abundance and the dynamic nature of these modifications. These difficulties are compounded with the lack of convenient affinity chromatography approaches to enrich modified proteins from complex cell extracts and determine the interdependence between different types of modifications. To address these challenges, we will develop specific enrichment and detection methods to identify and profile protein phosphorylation and sumoylation in human cells, and apply these technologies to determine paralog-specific SUMO substrates and how they are regulated in response to As2O3 and cytokines, which are known to affect protein sumoylation and subsequent proteasome degradation. The tools developed will be use to identify novel substrates, determine changes in site occupancy and correlate protein modifications with specific enzyme activities (e.g. modified sumoylated substrates targeted by specific E3 SUMO ligase or SUMO proteases). We anticipate that developments made as part of this proposal will not only expand the scope and application of large-scale proteomics and drug discovery programs but will also provide further insights on the regulation and significance of these modifications in human diseases.